Future Medicine

SHERPA: White

People

  1. Abou-Alfa
    Abou-Alfa
  2. D'Angelo
    D'Angelo
  3. Motzer
    Motzer
  4. Slovin
    Slovin
  5. Tap
    Tap

Groups

  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Gastrointestinal Oncology Service (2)
  4. Genitourinary Oncology Service (2)
  5. Hematologic Malignancies, Division of (2)
  6. Sarcoma Service (2)
Search Within
  1. "2020"
Formats
  1. Journal Article (4)
  2. Editorial (1)
  3. Review (1)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Gastrointestinal Oncology Service (2)
  4. Genitourinary Oncology Service (2)
  5. Hematologic Malignancies, Division of (2)
  6. Sarcoma Service (2)
People
  1. Ghassan Abou-Alfa (2)
  2. Robert Motzer (1)
  3. Sandra D'Angelo (1)
  4. Susan Slovin (1)
  5. William Tap (1)
Years
  1. 2020 (6)
Publications
  1. Future Oncology (5)
  2. Immunotherapy (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FIGHT-302: First-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
    Journal Article

    Bekaii-Saab, T. S.; Valle, J. W.; Van Cutsem, E.; Rimassa, L.; Furuse, J.; Ioka, T.; Melisi, D.; MacArulla, T.; Bridgewater, J.; Wasan, H.; more...
    Future Oncology (2020)

    Fulltext@MSK | Save
  • Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF 301 trial
    Journal Article

    Makawita, S.; Abou-Alfa, G. K.; Roychowdhury, S.; Sadeghi, S.; Borbath, I.; Goyal, L.; Cohn, A.; Lamarca, A.; Oh, D. Y.; MacArulla, T.; more...
    Future Oncology (2020)

    Fulltext@MSK | Save
  • Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab
    Journal Article

    Bharmal, M.; Nolte, S.; Lebbé, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Pusceddu, S.; Hanna, G. J.; Hassel, J. C.; more...
    Future Oncology (2020)

    Fulltext@MSK | Save
  • ENLIVEN study: Pexidartinib for tenosynovial giant cell tumor (TGCT)
    Review

    Tap, W.
    Future Oncology (2020)

    Fulltext@MSK | Save
  • Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinoma
    Journal Article

    Murphy, D. A.; Rini, B. I.; Escudier, B.; Motzer, R. J.; Wang, P.; Li, S.; Williams, J. A.; Tarazi, J. C.; Martini, J. F.
    Future Oncology (2020)

    Fulltext@MSK | Save
  • The challenge of checkpoint inhibitors in prostate cancer: Drugs for the many but useful to a few
    Editorial

    Slovin, S. F.
    Immunotherapy (2020)

    Fulltext@MSK | Save

    • Future Medicine – authorized name for: